Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Operating Expenses: 2015-2024

Historic Operating Expenses for Insight Molecular Diagnostics (IMDX) over the last 10 years, with Dec 2024 value amounting to $61.8 million.

  • Insight Molecular Diagnostics' Operating Expenses fell 17.53% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.7 million, marking a year-over-year increase of 46.09%. This contributed to the annual value of $61.8 million for FY2024, which is 141.81% up from last year.
  • As of FY2024, Insight Molecular Diagnostics' Operating Expenses stood at $61.8 million, which was up 141.81% from $25.5 million recorded in FY2023.
  • In the past 5 years, Insight Molecular Diagnostics' Operating Expenses ranged from a high of $61.8 million in FY2024 and a low of $18.0 million during FY2022.
  • Over the past 3 years, Insight Molecular Diagnostics' median Operating Expenses value was $25.5 million (recorded in 2023), while the average stood at $35.1 million.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Operating Expenses tumbled by 67.40% in 2022 and then soared by 141.81% in 2024.
  • Insight Molecular Diagnostics' Operating Expenses (Yearly) stood at $29.1 million in 2020, then spiked by 89.68% to $55.1 million in 2021, then plummeted by 67.40% to $18.0 million in 2022, then soared by 42.10% to $25.5 million in 2023, then surged by 141.81% to $61.8 million in 2024.